Femasys (FEMY) EBITDA Margin Growth (1y) (2021 - 2025)
Femasys (FEMY) EBITDA Margin Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 314.00 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -233.00 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -912.00 |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -306.00 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -418.00 |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 48.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -171.00 |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -2,130.00 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 53.00 |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 | -58,557.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 108,260.00 |
| Mar 31, 2025 | -32,304.00 |
| Dec 31, 2024 | 127,586.00 |
| Sep 30, 2024 | 74,778.00 |
| Jun 30, 2024 | -110,767.00 |
| Mar 31, 2024 | -24,243.00 |
| Dec 31, 2023 | -80,702.00 |
| Sep 30, 2023 | -79,030.00 |
| Jun 30, 2023 | -3,847.00 |
| Mar 31, 2023 | -13,772.00 |
| Dec 31, 2022 | -35,382.00 |
| Sep 30, 2022 | -4,471.00 |
| Jun 30, 2022 | -29,441.00 |
| Mar 31, 2022 | -34,304.00 |
| Dec 31, 2021 | -33,464.00 |
| Sep 30, 2021 | -33,554.00 |
| Jun 30, 2021 | 22,655.00 |